KMS Medisurgi Limited Stock Price Today (NSE: KMSMEDI)
Fundamental Score
KMS Medisurgi Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
KMS Medisurgi Limited share price today is ₹126.50, up +0.00% on NSE/BSE as of 30 March 2026. KMS Medisurgi Limited (KMSMEDI) is a Small-cap company in the Healthcare Equipment & Supplies sector with a market capitalisation of ₹41.75 (Cr). The 52-week high for KMSMEDI share price is ₹132.30 and the 52-week low is ₹120.50. At a P/E ratio of 94.89x, KMSMEDI is currently trading above its industry average P/E of 47.12x. The company has a Return on Equity (ROE) of 5.59% and a debt-to-equity ratio of 0.11.
KMS Medisurgi Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
KMS Medisurgi Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
KMS Medisurgi Share Price: A Conservative Investor's Perspective
The healthcare equipment and supplies sector is often considered defensive, but technological advancements and evolving regulatory landscapes introduce significant risk. This analysis provides a value-oriented assessment of the "KMS Medisurgi share price" based on publicly available data. Currently trading at ₹126.5, KMS Medisurgi exhibits a Price-to-Earnings (PE) ratio of 94.89. This high PE ratio necessitates a deep dive into the company's fundamentals to ascertain if future earnings growth can justify the premium.
A critical metric for value investors is Return on Capital Employed (ROCE). KMS Medisurgi's ROCE of 8.26% warrants careful consideration. While a positive ROCE indicates profitability, it's crucial to compare this figure against the company's cost of capital and industry benchmarks. A higher ROCE typically suggests a wider economic moat, indicating the company's ability to generate returns above its cost of capital consistently. An ROCE of 8.26%, however, may not be sufficient to establish a strong moat and protect against competitive pressures within the sector.
Management quality is paramount for sustainable value creation. Comparing KMS Medisurgi Limited with its peers,
Sector Benchmarks, particularly in areas like capital allocation and strategic decision-making, is essential. Are they reinvesting earnings wisely or diluting shareholder value through excessive spending or acquisitions? Understanding how KMS Medisurgi's management team operates relative to its competitors is crucial to assess its long-term viability.The relatively high PE ratio combined with a modest ROCE of 8.26% suggests that significant earnings growth is already priced into the KMS Medisurgi share price. From a conservative value investing perspective, further due diligence is required to understand the drivers of this valuation and whether it aligns with the company's ability to generate consistent, high-quality earnings in the long run. This assessment forms part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra, focusing on capital safety and downside protection.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
KMS Medisurgi Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KMSMEDI across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Robust Profit Growth (340.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (31.95% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (31.95% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (7.10x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (74.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (5.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.26%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 94.89x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Revenue Contraction (-9.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
KMS Medisurgi Limited Financial Statements
Comprehensive financial data for KMS Medisurgi Limited including income statement, balance sheet and cash flow
About KMSMEDI (KMS Medisurgi Limited)
KMS Medisurgi Limited is a dynamic global manufacturer and distributor specializing in medical equipment and supplies. The company has carved a niche for itself in the internationa...l healthcare market by focusing on high-quality surgical equipment and advanced wound care solutions. It expertly combines innovation with practicality, resulting in a diverse product line designed to meet the rigorous demands of modern medical practices. KMS Medisurgi prides itself on its commitment to stringent quality control and adherence to global regulatory standards, ensuring that its products are reliable and effective across a broad spectrum of clinical applications. KMS Medisurgi's products are meticulously engineered to improve patient outcomes and enhance the efficiency of healthcare professionals. KMS Medisurgi's core strength lies in its comprehensive range of surgical and wound care products. These offerings encompass a wide variety of specialized tapes, including breathable microporous, gentle paper, crystal-clear transparent, cushioning gel, delicate silicone, classic silk, and protective foam options. Moreover, the company also provides adhesive tapes compliant with U.S. Pharmacopeia (USP) standards and non-woven surgical tapes with acrylic adhesive. This extensive portfolio demonstrates KMS Medisurgi's dedication to providing healthcare providers with the best tools for surgery and wound care, all designed with patient comfort and optimal healing in mind. These products are developed with careful consideration for the diverse needs of patients and clinicians, solidifying the company’s position as a leader in the field. KMS Medisurgi extends its reach across a vast international network, supplying its products to healthcare providers in key markets around the globe. Its products are present in diverse locations such as India, Dubai, Vietnam, Australia, Cambodia, Africa, the Philippines, Russia, Pakistan, Europe, Bangladesh, and the United States, the company is committed to providing a reliable supply of high-quality medical equipment and supplies to medical professionals worldwide. KMS Medisurgi remains focused on expanding its global presence through strategic partnerships and continued innovation, always striving to improve healthcare outcomes and enhance the quality of patient care.
Company Details
Key Leadership
Corporate Events
KMSMEDI Share Price: Frequently Asked Questions
What is the current share price of KMS Medisurgi Limited (KMSMEDI)?
As of 30 Mar 2026, 12:04 pm IST, KMS Medisurgi Limited share price is ₹126.50. The KMSMEDI stock has a market capitalisation of ₹41.75 (Cr) on NSE/BSE.
Is KMSMEDI share price Overvalued or Undervalued?
KMSMEDI share price is currently trading at a P/E ratio of 94.89x, compared to the industry average of 47.12x. Based on this relative valuation, the KMS Medisurgi Limited stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of KMSMEDI share price?
The 52-week high of KMSMEDI share price is ₹132.30 and the 52-week low is ₹120.50. These values are updated daily from NSE/BSE price data.
What factors affect the KMS Medisurgi Limited share price?
Key factors influencing KMSMEDI share price include quarterly earnings growth (Sales Growth: -9.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is KMS Medisurgi Limited a good stock for long-term investment?
KMS Medisurgi Limited shows a 5-year Profit Growth of 31.95% and an ROE of 5.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing in KMSMEDI shares.
How does KMS Medisurgi Limited compare with its industry peers?
KMS Medisurgi Limited competes with major peers in the Healthcare Equipment & Supplies. Investors should compare KMSMEDI share price P/E of 94.89x and ROE of 5.59% against the industry averages to determine competitive standing.
What is the P/E ratio of KMSMEDI and what does it mean?
KMSMEDI share price has a P/E ratio of 94.89x compared to the industry average of 47.12x. Investors pay ₹95 for every ₹1 of annual earnings.
How is KMSMEDI performing according to Bull Run's analysis?
KMSMEDI has a Bull Run fundamental score of 43.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does KMSMEDI belong to?
KMSMEDI operates in the Healthcare Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting KMS Medisurgi Limited share price.
What is Return on Equity (ROE) and why is it important for KMSMEDI?
KMSMEDI has an ROE of 5.59%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently KMS Medisurgi Limited generates profits from shareholders capital.
How is KMSMEDI debt-to-equity ratio and what does it indicate?
KMSMEDI has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk.
What is KMSMEDI dividend yield and is it a good dividend stock?
KMSMEDI offers a dividend yield of 0.04%, meaning you receive ₹0.04 annual dividend for every ₹100 invested in KMS Medisurgi Limited shares.
How has KMSMEDI share price grown over the past 5 years?
KMSMEDI has achieved 5-year growth rates of: Sales Growth 6.16%, Profit Growth 31.95%, and EPS Growth 31.95%.
What is the promoter holding in KMSMEDI and why does it matter?
Promoters hold 74.42% of KMSMEDI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in KMS Medisurgi Limited.
What is KMSMEDI market capitalisation category?
KMSMEDI has a market capitalisation of ₹42 crores, placing it in the Small-cap category.
How volatile is KMSMEDI stock?
KMSMEDI has a beta of N/A. A beta > 1 suggests the KMS Medisurgi Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is KMSMEDI operating profit margin trend?
KMSMEDI has a 5-year average Operating Profit Margin (OPM) of 6.69%, indicating the company's operational efficiency.
How is KMSMEDI quarterly performance?
Recent quarterly performance shows KMS Medisurgi Limited YoY Sales Growth of -9.06% and YoY Profit Growth of 340.00%.
What is the institutional holding pattern in KMSMEDI?
KMSMEDI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the KMS Medisurgi Limited stock.